Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Nonexudative Age-Related Macular Degeneration, Bilateral, Intermediate Dry Stage (H35.3132)
Summary
Nonexudative age-related macular degeneration (AMD) is a chronic eye condition affecting the macula, the central part of the retina responsible for sharp central vision. This bilateral, intermediate dry stage involves gradual macular degeneration without fluid leakage or bleeding, leading to moderate vision impairment. It is commonly referred to as "dry AMD" and progresses slower than its exudative counterpart.
Causes
The exact cause is unknown, but it involves the degeneration of retinal cells and the accumulation of drusen (yellow deposits) under the retina. Oxidative stress and impaired cellular debris removal are suspected contributors to this intermediate-stage process.
Risk Factors
- Age (most common in individuals over 60)
- Family history of AMD
- Smoking
- High blood pressure and cholesterol
- Obesity
- Prolonged sunlight exposure
- Poor diet low in antioxidants
Symptoms
- Blurred or reduced central vision
- Difficulty recognizing faces
- Need for brighter light when reading
- Gradual difficulty adapting to low light levels
Diagnosis
Diagnosis requires a comprehensive eye examination, including dilation to assess the macula. Optical coherence tomography (OCT) visualizes retinal layers, and an Amsler grid test detects vision distortions. Fundus photography may document macular changes.
Treatment Options
- No cure exists, but progression can be slowed.
- Nutritional supplements (e.g., AREDS/AREDS2 formulations)
- Regular monitoring to detect progression to advanced stages
Prognosis and Follow-Up
Prognosis varies, but vision loss typically progresses slowly. Regular follow-up with an eye care professional is essential to monitor for progression to advanced stages, such as geographic atrophy or neovascularization. Early detection of changes allows for timely intervention if needed.
Complications
- Progression to advanced dry AMD (e.g., geographic atrophy)
- Increased risk of developing exudative (wet) AMD
- Significant central vision loss affecting daily activities
Lifestyle & Prevention
- Quit smoking
- Maintain a diet rich in antioxidants (leafy greens, fish)
- Protect eyes from UV exposure with sunglasses
- Manage blood pressure and cholesterol
- Exercise regularly to support overall health
When to Seek Professional Help
Seek immediate care if you experience sudden vision changes, such as straight lines appearing wavy, new blind spots, or rapid vision loss, as these may indicate progression to exudative AMD or other serious conditions.
Tips for Medical Coders
Document the bilateral involvement and intermediate dry stage clearly in clinical notes. Ensure the diagnosis aligns with the presence of drusen and retinal changes consistent with this stage. Use this code only when the condition is confirmed as nonexudative and at the intermediate dry stage.
Medical Policies and Guidelines
Related policies from health plans
H35.3132 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.